A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis

E Strijbos; MR Tannemaat; I Alleman; RHP de Meel; JA Bakker; Ruud Beek; FP Kroon; GF Rimmelzwaan; J Verschuuren

doi:10.1016/j.vaccine.2019.01.007

A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis

E Strijbos, MR Tannemaat, I Alleman, RHP de Meel, JA Bakker, Ruud Beek, FP Kroon, GF Rimmelzwaan, J Verschuuren

Virology

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	919-925
Number of pages	7
Journal	Vaccine
Volume	37
Issue number	7
DOIs	https://doi.org/10.1016/j.vaccine.2019.01.007
Publication status	Published - 2019

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2019.01.007

http://hdl.handle.net/1765/115191

Cite this

@article{b0ac38c07ed24f799c9ec83a3ddfc015,

title = "A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis",

author = "E Strijbos and MR Tannemaat and I Alleman and \{de Meel\}, RHP and JA Bakker and Ruud Beek and FP Kroon and GF Rimmelzwaan and J Verschuuren",

year = "2019",

doi = "10.1016/j.vaccine.2019.01.007",

language = "Undefined/Unknown",

volume = "37",

pages = "919--925",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis

AU - Strijbos, E

AU - Tannemaat, MR

AU - Alleman, I

AU - de Meel, RHP

AU - Bakker, JA

AU - Beek, Ruud

AU - Kroon, FP

AU - Rimmelzwaan, GF

AU - Verschuuren, J

PY - 2019

Y1 - 2019

U2 - 10.1016/j.vaccine.2019.01.007

DO - 10.1016/j.vaccine.2019.01.007

M3 - Article

SN - 0264-410X

VL - 37

SP - 919

EP - 925

JO - Vaccine

JF - Vaccine

IS - 7

ER -